Inhibin A
Inhibin A, Serum
Test
Method
Immunoassay (IA)
Platform
Beckman-Coulter CLIA
Report Includes
Specimens
Serum
Clinical Utility
Inhibin A is useful as an indicator of gonadal function, and ovarian response to hMg or to FSH stimulation. Inhibin A, produced by the placenta, is used along with other maternal serum biochemical markers to improve sensitivity of the screen for Down Syndrome risk.
This test was performed using the Beckman-Coulter Chemiluminescent Inhibin-A method that has been cleared by the FDA strictly for in vitro use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders. The Inhibin-A test should not be used as a diagnostic procedure for granulosa cell tumors or hydatidiform moles without confirmation of the diagnosis by another established product or procedure. Values obtained with different assay methods or kits cannot be used interchangeably.
Test Location
Quest Diagnostics, California USA
Test Version
1-Nov-2022
Specimen
Specimens
Serum
Collection Containers
Gold top (clot activator & gel)
Sample Volume
2.0 ml
Minimum Volume
0.5 ml
Collection & Handling
Collection Instructions
When ordered with Inhibin B, Serum, a separate aliquot must be submitted.
Stability
Ambient | 14 days |
---|---|
Refrigerated | 14 days |
Frozen | 28 days |
Rejection Criteria
Hemolysis | Gross |
---|---|
Lipemia | Gross |
Test Version
1-Nov-2022
Performance / Interpretation
Method
Immunoassay (IA)
Platform
Beckman-Coulter CLIA
Turnaround Time
8 days
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Inhibin A | pg/mL |
|
||
This test was performed using the Beckman-Coulter Chemiluminescent Inhibin-A method that has been cleared by the FDA strictly for in vitro use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders. The Inhibin-A test should not be used as a diagnostic procedure for granulosa cell tumors or hydatidiform moles without confirmation of the diagnosis by another established product or procedure. Values obtained with different assay methods or kits cannot be used interchangeably.
|
Test Location
Quest Diagnostics, California USA
Test Version
1-Nov-2022
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
INHIBA S | 64095INHIBIN A | pg/mL |
Test Version
1-Nov-2022